Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells

• Molly DiScala ,

  Contributed equally to this work with: Molly DiScala, Matthew S. Najor

  Roles Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing

  Affiliation Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America

  ⨯
• Matthew S. Najor ,

  Contributed equally to this work with: Molly DiScala, Matthew S. Najor

  Roles Conceptualization, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America

  ⨯
• Timothy Yung,

  Roles Investigation, Validation, Writing – original draft, Writing – review & editing

  Affiliation Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America

  ⨯
• Deri Morgan,

  Roles Data curation, Formal analysis, Investigation, Validation, Writing – review & editing

  Affiliation Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Missouri, United States of America

  ⨯
• Abde M. Abukhdeir ,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: abde_abukhdeir@rush.edu

  Affiliation Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America

  http://orcid.org/0000-0003-1172-5819

  ⨯
• Melody A. Cobleigh

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing

  Affiliation Division of Hematology, Oncology, and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois, United States of America

  ⨯